Abstract:Low photoconversion efficiency and limited tissue penetration are the major barriers for photothermal therapy (PTT) agent application. Here, an efficient organic/inorganic dual‐PTT agent guided by MRI was proposed. It is proved the oxygen vacancy band narrowed its band gap that led to NIR‐II region absorb. Furthermore, the defect energy level trapping carrier and conjugate synergistic heat generation result in high photoconversion efficiency. Photothermal therapy (PTT), as an important noninvasive and effective tumor treatment method, has been extensively developed into a powerful cancer therapeutic technique. Nevertheless, the low photothermal conversion efficiency and the limited tissue penetration of typical photothermal therapeutic agents in the first near‐infrared (NIR‐I) region (700–950 nm) are still the major barriers for further clinical application. Here, we proposed an organic/inorganic dual‐PTT agent of synergistic property driven by polydopamine‐modified black‐titanium dioxide (b‐TiO2@PDA) with excellent photoconversion efficiency in the second NIR (NIR‐II) region (1000–1500 nm). More specifically, the b‐TiO2 treated with sodium borohydride produced excessive oxygen vacancies resulting in oxygen vacancy band that narrowed the b‐TiO2 band gap, and the small band gap led to NIR‐II region wavelength (1064 nm) absorbance. Furthermore, the combination of defect energy level trapping carrier recombination heat generation and conjugate heat generation mechanism, significantly improved the photothermal performance of the PTT agent based on b‐TiO2. The photothermal properties characterization indicated that the proposed dual‐PTT agent possesses excellent photothermal performance and ultra‐high photoconversion efficiency of 64.9% under 1064 nm laser irradiation, which can completely kill esophageal squamous cells. Meanwhile, Gd2O3 nanoparticles, an excellent magnetic resonance imaging (MRI) agent, were introduced into the nanosystem with similar dotted core–shell structure to enable the nanosystem achieve real‐time MRI‐monitored cancer therapeutic performance. We believe that this integrated nanotherapeutic system can not only solve the application of PTT in the NIR‐II region, but also provide certain theoretical guidance for the clinical diagnosis and treatment of esophageal cancer.

“Internal and External Combined” Nonradiative Decay-Based Nanoagents for Photoacoustic Image-Guided Highly Efficient Photothermal Therapy

Small-Molecule Porphyrin-Based Organic Nanoparticles with Remarkable Photothermal Conversion Efficiency for in Vivo Photoacoustic Imaging and Photothermal Therapy.

Förster Resonance Energy Transfer Nanobullet for Photoacoustic Imaging and Amplified Photothermal‐Photodynamic Therapy of Cancer

Pyrazino[2,3-g]quinoxaline-Based Nanoparticles as Near-Infrared Phototheranostic Agents for Efficient Photoacoustic-Imaging-Guided Photothermal Therapy

A-DA′D-A Structured Organic Phototheranostics for NIR-II Fluorescence/Photoacoustic Imaging-Guided Photothermal and Photodynamic Synergistic Therapy

Highly Stable Organic Small Molecular Nanoparticles As an Advanced and Biocompatible Phototheranostic Agent of Tumor in Living Mice

Aggregation-Induced Emission-Active Organic Nanoagent with High Photothermal Conversion Efficiency for Near-Infrared Imaging-Guided Tumor Photothermal Therapy

Acceptor-donor-acceptor type organic photothermal agents with enhanced NIR absorption and photothermal conversion effect for cancer photothermal therapy

Small‐Molecule Phototheranostic Agent with Extended π‐Conjugation for Efficient NIR‐II Photoacoustic‐Imaging‐Guided Photothermal Therapy

Gold Nanostar@Polyaniline Theranostic Agent with High Photothermal Conversion Efficiency for Photoacoustic Imaging-Guided Anticancer Phototherapy at a Low Dosage.

Manipulating Nonradiative Decay Channel by Intermolecular Charge Transfer for Exceptionally Improved Photothermal Conversion.

Gadolinium-Chelated Conjugated Polymer-Based Nanotheranostics for Photoacoustic/Magnetic Resonance/NIR-II Fluorescence Imaging-Guided Cancer Photothermal Therapy

Stable Organic Photosensitizer Nanoparticles with Absorption Peak beyond 800 Nanometers and High Reactive Oxygen Species Yield for Multimodality Phototheranostics

Novel small molecule-based organic nanoparticles for second near-infrared photothermal tumor ablation

Acceptor-donor-acceptor-type Molecules with large electrostatic potential difference for Effective NIR Photothermal Theranostics

A novel activated NIR-II phototheranostic nanoagent and its application to photothermal therapy

NIR-controlled HSP90 Inhibitor Release from Hollow Mesoporous Nanocarbon for Synergistic Tumor Photothermal Therapy Guided by Photoacoustic Imaging

Near-infrared-II Light Excitation Thermosensitive Liposomes for Photoacoustic Imaging-Guided Enhanced Photothermal-Chemo Synergistic Tumor Therapy

Self‐Regenerating Photothermal Agents for Tandem Photothermal and Thermodynamic Tumor Therapy

Gd2O3/b‐TiO2 composite nanoprobes with ultra‐high photoconversion efficiency for MR image‐guided NIR‐II photothermal therapy

Second Near-Infrared Conjugated Polymer Nanoparticles for Photoacoustic Imaging and Photothermal Therapy.